Gül Fethi, Arslantaş Mustafa Kemal, Cinel İsmail, Kumar Anand
Department of Anaesthesiology and Reanimation, Marmara University Pendik Training and Research Hospital, İstanbul, Turkey.
Department of Anaesthesiology and Reanimation, Marmara University School of Medicine, İstanbul, Turkey.
Turk J Anaesthesiol Reanim. 2017 Jun;45(3):129-138. doi: 10.5152/TJAR.2017.93753. Epub 2017 Feb 1.
Sepsis is one of the main causes of morbidity and mortality in critically ill patients despite the use of modern antibiotics and resuscitation therapies. Outcomes in sepsis have improved overall, probably because of an enhanced focus on early diagnosis and other improvements in supportive care, but mortality rates still remain unacceptably high. The diagnosis and definition of sepsis is a critical problem due to the heterogeneity of this disease process. Although it is apparent that much more needs to be done to advance our understanding, sepsis and related terms remain difficult to define. A 1991 consensus conference developed initial definitions that systemic inflammatory response syndrome (SIRS) to infection would be called sepsis. Definitions of sepsis and septic shock were revised in 2001 to incorporate the threshold values for organ damage. In early 2016, the new definitions of sepsis and septic shock have changed dramatically. Sepsis is now defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. The consensus document describes organ dysfunction as an acute increase in total Sequential Organ Failure Assessment (SOFA) score two points consequently to the infection. A significant change in the new definitions is the elimination of any mention of SIRS. The Sepsis-3 Task Force also introduced a new bedside index, called the qSOFA, to identify outside of critical care units patients with suspected infection who are likely to develop sepsis. Recently updated the consensus definitions improved specificity compared with the previous descriptions.
尽管使用了现代抗生素和复苏治疗方法,但脓毒症仍是重症患者发病和死亡的主要原因之一。脓毒症的总体预后有所改善,这可能是因为对早期诊断的关注度提高以及支持治疗的其他改进,但死亡率仍然高得令人无法接受。由于该疾病过程的异质性,脓毒症的诊断和定义是一个关键问题。尽管显然需要做更多工作来增进我们的理解,但脓毒症及相关术语仍然难以定义。1991年的一次共识会议制定了初步定义,即对感染的全身炎症反应综合征(SIRS)将被称为脓毒症。2001年对脓毒症和感染性休克的定义进行了修订,纳入了器官损伤的阈值。2016年初,脓毒症和感染性休克的新定义发生了巨大变化。现在脓毒症被定义为由宿主对感染的反应失调引起的危及生命的器官功能障碍。该共识文件将器官功能障碍描述为感染后序贯器官衰竭评估(SOFA)总分急性增加2分。新定义中的一个重大变化是不再提及SIRS。脓毒症-3特别工作组还引入了一种新的床旁指标,称为快速序贯器官衰竭评估(qSOFA),以识别重症监护病房以外疑似感染且可能发展为脓毒症的患者。最近更新的共识定义与之前的描述相比提高了特异性。